113 related articles for article (PubMed ID: 1803617)
1. Lipoprotein associated coagulation inhibitor, factor VII, antithrombin III, and monocyte tissue factor following surgery.
Carson SD; Haire WD; Broze GJ; Novotny WF; Pirrucello SJ; Duggan MJ
Thromb Haemost; 1991 Nov; 66(5):534-9. PubMed ID: 1803617
[TBL] [Abstract][Full Text] [Related]
2. The lipoprotein-associated coagulation inhibitor.
Broze GJ; Girard TJ; Novotny WF
Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
[TBL] [Abstract][Full Text] [Related]
3. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
4. Extrinsic pathway inhibitor in elective surgery: a comparison with other coagulation inhibitors.
Sandset PM; Høgevold HE; Lyberg T; Andersson TR; Abildgaard U
Thromb Haemost; 1989 Nov; 62(3):856-60. PubMed ID: 2595660
[TBL] [Abstract][Full Text] [Related]
5. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
[TBL] [Abstract][Full Text] [Related]
6. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.
Sandset PM; Larsen ML; Abildgaard U; Lindahl AK; Odegaard OR
Blood Coagul Fibrinolysis; 1991 Jun; 2(3):425-33. PubMed ID: 1932528
[TBL] [Abstract][Full Text] [Related]
8. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
Chang YJ; Hamaguchi N; Chang SC; Ruf W; Shen MC; Lin SW
Biochemistry; 1999 Aug; 38(34):10940-8. PubMed ID: 10460149
[TBL] [Abstract][Full Text] [Related]
9. Characterization with a simple clotting assay of the tissue factor inhibiting activity in serum.
Cassetti M; Minestrini D; Palazzesi G
Haematologica; 1990; 75(1):32-7. PubMed ID: 2242114
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Osterud B; Due J
Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentration of tissue factor and factor VII in patients after abdominal surgery.
Albrecht S; Müller S; Siegert G; Luther T; Müller M
Thromb Res; 1995 Mar; 77(6):557-62. PubMed ID: 7624841
[TBL] [Abstract][Full Text] [Related]
12. Tissue thromboplastin generation in circulating mononuclear phagocytes and development of coagulation disorders during E. coli endotoxinaemia in pigs.
Andersen OK; Osterud B; Gaudernack G; Lundgren TI; Giercksky KE
Acta Chir Scand; 1985; 151(3):205-11. PubMed ID: 3925666
[TBL] [Abstract][Full Text] [Related]
13. [Observation on tissue factor pathway during the onset of acute cerebral infarction].
Wen ZB; Xiong SL; He XF; He MX; He SL; Xie QZ; Jian ZF; Chen FP; Xiao B; Yang QD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):529-31. PubMed ID: 12971845
[TBL] [Abstract][Full Text] [Related]
14. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.
Girard TJ; Warren LA; Novotny WF; Likert KM; Brown SG; Miletich JP; Broze GJ
Nature; 1989 Apr; 338(6215):518-20. PubMed ID: 2927510
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
[TBL] [Abstract][Full Text] [Related]
16. Plasma von Willebrand factor and antithrombin III in patients submitted to open heart surgery.
Bódizs G; Brudaşca I; Aldica M; Cucuianu M
Rom J Intern Med; 1994; 32(4):259-64. PubMed ID: 7613497
[TBL] [Abstract][Full Text] [Related]
17. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor expression during monocyte-macrophage differentiation.
van den Eijnden MM; Steenhauer SI; Reitsma PH; Bertina RM
Thromb Haemost; 1997 Jun; 77(6):1129-36. PubMed ID: 9241745
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
20. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
